5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow Carcinosarcoma: new trials by email Literature Review of Carcinosarcoma trials Research Report on Carcinosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ZW25 in Women With Endometrial Cancers ZW25 - Endometrial Cancer, Carcinosarcoma | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 16 | 2020-08-12 | 2025-05-22 |
| A Study of DKN-01 as a Monotherapy or in Combination With Paclitaxel in Patients With Recurrent Epithelial Endometrial or Epithelial Ovarian Cancer or Carcinosarcoma Paclitaxel, 300mg DKN-01, 600mg DKN-01 - Endometrial Cancer, Uterine Cancer | Phase 2 | Completed | Leap Therapeutics, Inc. | 111 | 2018-03-05 | 2025-08-01 |
| A Study of Nivolumab in Selected Uterine Cancer Patients Nivolumab - Uterine Cancer, Endometrial Carcinoma | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 35 | 2017-08-03 | 2024-12-27 |
| Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS) Trabectedin - Carcinosarcoma, Ovarian, Carcinosarcomas Uterine | Phase 2 | Completed | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 45 | 2017-02-22 | 2021-08-25 |
| Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors PegLiposomal Doxorubicin, Carboplatin - Mesenchymal Tumor, Carcinosarcoma | Phase 2 | Completed | AGO Study Group | 41 | 2008-06-01 | 2017-02-14 |
Endometrial Neoplasms (3) · Leiomyosarcoma (2) · Uterine Neoplasms (2) · Adenocarcinoma, Clear Cell (1) · Ovarian Neoplasms (1)
Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms, Complex and Mixed (5) · Neoplasms, Connective and Soft Tissue (5) · Sarcoma (5) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Neoplasms by Site (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Uterine Diseases (3) · Neoplasms, Muscle Tissue (2)
Carboplatin (1) · Nivolumab (1) · Paclitaxel (1) · Trabectedin (1) · liposomal doxorubicin (1)
Memorial Sloan Kettering Cancer Center (2) · AGO Study Group (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Leap Therapeutics, Inc. (1)
United States (3) · Germany (1) · Italy (1)
Claire Friedman, MD (1) · Cynthia Sirard (1) · Domenica Lorusso, Prof. (1) · Philipp Harter, MD (1) · Vikky Makker, MD (1)
PMID 10655437, PMID 11063636, PMID 11304695, PMID 11479630, PMID 15350372, PMID 15721404, PMID 16271748, PMID 17290061, PMID 17395252, PMID 17822748, PMID 17936342, PMID 18378136, PMID 18755503, PMID 23397080, PMID 23410977, PMID 25341582, PMID 37001446, PMID 38262242, PMID 38653864